Elicio Therapeutics, Inc.
ELTX
$10.60
-$0.43-3.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.61M | -51.28M | -51.90M | -46.84M | -38.67M |
| Total Depreciation and Amortization | 1.15M | 1.17M | 1.18M | 1.16M | 1.14M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.63M | 8.68M | 9.69M | 8.82M | -256.00K |
| Change in Net Operating Assets | 4.74M | 6.37M | 3.96M | -1.36M | 1.65M |
| Cash from Operations | -35.09M | -35.07M | -37.07M | -38.22M | -36.13M |
| Capital Expenditure | -45.00K | -87.00K | -87.00K | -42.00K | -87.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 3.00K | 3.00K | 3.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -45.00K | -87.00K | -84.00K | -39.00K | -84.00K |
| Total Debt Issued | 29.59M | 19.73M | 19.73M | 19.73M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.20M | 22.45M | 23.14M | 29.92M | 18.40M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -549.00K | -549.00K | -549.00K | -547.00K | 2.00K |
| Cash from Financing | 53.24M | 41.63M | 42.32M | 49.10M | 18.40M |
| Foreign Exchange rate Adjustments | 168.00K | 53.00K | 22.00K | -5.00K | -39.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.28M | 6.53M | 5.19M | 10.83M | -17.85M |